Sangamo Therapeutics Statistics

Total Valuation

LON:0R1D has a market cap or net worth of GBP 127.42 million. The enterprise value is 124.27 million.

Market Cap	127.42M
Enterprise Value	124.27M

Important Dates

The next estimated earnings date is Thursday, March 19, 2026.

Earnings Date	Mar 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	336.49M
Shares Outstanding	n/a
Shares Change (YoY)	+28.22%
Shares Change (QoQ)	+18.42%
Owned by Insiders (%)	1.28%
Owned by Institutions (%)	18.68%
Float	328.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.21
PB Ratio	27.44
P/TBV Ratio	27.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.53
EV / Sales	5.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.19

Financial Position

The company has a current ratio of 0.88, with a Debt / Equity ratio of 4.07.

Current Ratio	0.88
Quick Ratio	0.69
Debt / Equity	4.07
Debt / EBITDA	n/a
Debt / FCF	-0.33
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -480.02% and return on invested capital (ROIC) is -138.19%.

Return on Equity (ROE)	-480.02%
Return on Assets (ROA)	-68.11%
Return on Invested Capital (ROIC)	-138.19%
Return on Capital Employed (ROCE)	-282.79%
Revenue Per Employee	133,645
Profits Per Employee	-442,742
Employee Count	183
Asset Turnover	0.33
Inventory Turnover	n/a

Taxes

Income Tax	-328,821
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.29% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-75.29%
50-Day Moving Average	0.56
200-Day Moving Average	0.61
Relative Strength Index (RSI)	51.69
Average Volume (20 Days)	174,141

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.81

Income Statement

In the last 12 months, LON:0R1D had revenue of GBP 24.46 million and -81.02 million in losses. Loss per share was -0.33.

Revenue	24.46M
Gross Profit	-53.59M
Operating Income	-81.03M
Pretax Income	-81.35M
Net Income	-81.02M
EBITDA	-77.88M
EBIT	-81.03M
Loss Per Share	-0.33

Full Income Statement

Balance Sheet

The company has 22.03 million in cash and 18.91 million in debt, giving a net cash position of 3.12 million.

Cash & Cash Equivalents	22.03M
Total Debt	18.91M
Net Cash	3.12M
Net Cash Per Share	n/a
Equity (Book Value)	4.64M
Book Value Per Share	0.01
Working Capital	-4.50M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -56.66 million and capital expenditures -178,546, giving a free cash flow of -56.83 million.

Operating Cash Flow	-56.66M
Capital Expenditures	-178,546
Free Cash Flow	-56.83M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	-219.11%
Operating Margin	-331.33%
Pretax Margin	-332.63%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0R1D does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.22%
Shareholder Yield	-28.22%
Earnings Yield	-63.59%
FCF Yield	-44.60%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0R1D has an Altman Z-Score of -27.24 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-27.24
Piotroski F-Score	2